Digital Health Roundup, 20 July 2021 – Digital Health Funding, ADA 2021, Telehealth

In this month’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering offer a recap of Medtech Insight’s digital health coverage in June, including the record-breaking H1 digital health funding, a recap of ADA 2021 and updates on telehealth legislation. Medtech Insight articles addressing topics discussed in this episode: Quanta Raises $245M In Series D, Plans To Expand Into Home-Based Dialysis In US https://medtech.pharmaintelligence.informa.com/MT144130/Quanta-Raises-245M-In-Series-D-Plans-To-Expand-Into-HomeBased-Dialysis-In-US CMR Surgical Closes SoftBank-Led Funding Round Worth $600M https://medtech.pharmaintelligence.informa.com/MT144132/CMR-Surgical-Closes-SoftBank-Led-Funding-Round-Worth-$600M Pear Therapeutics Goes Public To Support Expansion Of Prescription Digital Therapeutics https://medtech.pharmaintelligence.informa.com/MT144127/Exec-Chat-Pear-Therapeutics-CEO-Charts-Future-For-Digital-Therapeutics-Following-SPAC-Deal ADA 2021: Encouraging Trial Data on CGMs, Insulin Pens, Digital Solutions, And More https://medtech.pharmaintelligence.informa.com/MT144145/ADA-2021-Encouraging-Trial-Data-On-CGMs-Insulin-Pens-Digital-Solutions-And-More Exec Chat: Dexcom Continues To Evolve Blood Glucose Measurement Market https://medtech.pharmaintelligence.informa.com/MT144175/Exec-Chat-Dexcom-Continues-To-Evolve-Blood-Glucose-Measurement-Market Cures 2.0 Would Circumvent CMS’ Pause On Breakthrough Payment Rule, Improve Telehealth, And More https://medtech.pharmaintelligence.informa.com/MT144113/Cures-20-Would-Circumvent-CMS-Pause-On-Breakthrough-Payment-Rule-Improve-Telehealth-And-More MDUFA V: Industry, FDA Tangle Over TAP Program, Agency Finances, Reinstatement Of Fifth-Year Offset Funds https://medtech.pharmaintelligence.informa.com/MT144183/MDUFA-V-Industry-FDA-Tangle-Over-TAP-Program-Agency-Finances-Reinstatement-Of-FifthYear-Offset-Funds For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR